Last 12 months
Inside the activity.
12 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 8 | 2 |
| Dec 2025 | 4 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 18, 2024 Filed Nov 20, 2024 21:17 UTC |
Moore Stephen MichaelSVP and Chief Legal Officer
|
SaleCommon Stock | 1,693 | $3.79 | $6,416.47 |
DisclosureSEC source: 0001415889-24-027343 · form4-11202024_091159.xml · nonDerivative · entry 1 Moore Stephen Michael · CIK 0001915342 · SVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,388 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $3.76 to $3.79 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:15 UTC |
Hall Christopher MDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 26,443 | $5.38 | $142,263.34 |
DisclosureSEC source: 0001415889-24-026124 · form4-11052024_041104.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,098 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $5.05 to $5.58 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| August 16, 2024 Filed Aug 20, 2024 20:17 UTC |
Tempus AI, Inc.10% owner
|
OtherWarrant (Right to Buy) · Derivative | 4,609,400 | Not disclosed Strike: $2.50 | Not disclosed |
DisclosureSEC source: 0001493152-24-033271 · ownership.xml · derivative · entry 5 Tempus AI, Inc. · CIK 0001717115 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,609,400 shares Expires 2025-12-31 F1 · price: The Reporting Person acquired the warrants as partial consideration for its obligations to the Issuer under that certain Commercialization and Reference Laboratory Agreement, dated November 25, 2023, between the Issuer and the Reporting Person. Read SEC document |
| August 16, 2024 Filed Aug 20, 2024 20:17 UTC |
Tempus AI, Inc.10% owner
|
OtherWarrant (Right to Buy) · Derivative | 4,609,400 | Not disclosed Strike: $1.50 | Not disclosed |
DisclosureSEC source: 0001493152-24-033271 · ownership.xml · derivative · entry 4 Tempus AI, Inc. · CIK 0001717115 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,609,400 shares Expires 2024-12-31 F1 · price: The Reporting Person acquired the warrants as partial consideration for its obligations to the Issuer under that certain Commercialization and Reference Laboratory Agreement, dated November 25, 2023, between the Issuer and the Reporting Person. Read SEC document |
| August 16, 2024 Filed Aug 20, 2024 20:17 UTC |
Tempus AI, Inc.10% owner
|
PurchaseCommon Stock | 3,500,000 | $5.07 | $17,745,000.00 |
DisclosureSEC source: 0001493152-24-033271 · ownership.xml · nonDerivative · entry 3 Tempus AI, Inc. · CIK 0001717115 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,718,800 Read SEC document |
| August 16, 2024 Filed Aug 20, 2024 20:17 UTC |
Tempus AI, Inc.10% owner
|
OtherCommon Stock | 4,609,400 | $2.50 | $11,523,500.00 |
DisclosureSEC source: 0001493152-24-033271 · ownership.xml · nonDerivative · entry 2 Tempus AI, Inc. · CIK 0001717115 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,218,800 Read SEC document |
| August 16, 2024 Filed Aug 20, 2024 20:17 UTC |
Tempus AI, Inc.10% owner
|
OtherCommon Stock | 4,609,400 | $1.50 | $6,914,100.00 |
DisclosureSEC source: 0001493152-24-033271 · ownership.xml · nonDerivative · entry 1 Tempus AI, Inc. · CIK 0001717115 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,609,400 Read SEC document |
| July 30, 2024 Filed Aug 1, 2024 21:13 UTC |
Tachibana AaronCFO AND COO
|
SaleCommon Stock | 742 | $2.97 | $2,203.74 |
DisclosureSEC source: 0001415889-24-020533 · form4-08012024_090847.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · CFO AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,270 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $2.97 to $3.01 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| July 30, 2024 Filed Aug 1, 2024 21:16 UTC |
Chen RichardCHIEF MEDICAL OFFICER AND EVP
|
SaleCommon Stock | 524 | $2.97 | $1,556.28 |
DisclosureSEC source: 0001415889-24-020534 · form4-08012024_090856.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,227 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $2.97 to $3.02 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 20:54 UTC |
Tachibana AaronCFO AND COO
|
SaleCommon Stock | 7,176 | $1.29 | $9,257.04 |
DisclosureSEC source: 0001415889-24-017683 · form4-06202024_080625.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · CFO AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,012 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $1.26 to $1.29 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 20:55 UTC |
Chen RichardCHIEF MEDICAL OFFICER AND EVP
|
SaleCommon Stock | 5,055 | $1.29 | $6,520.95 |
DisclosureSEC source: 0001415889-24-017684 · form4-06202024_080625.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,751 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $1.26 to $1.29 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 20:53 UTC |
Moore Stephen MichaelSVP and Chief Legal Officer
|
SaleCommon Stock | 1,585 | $1.29 | $2,044.65 |
DisclosureSEC source: 0001415889-24-017682 · form4-06202024_080603.xml · nonDerivative · entry 1 Moore Stephen Michael · CIK 0001915342 · SVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,081 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $1.27 to $1.29 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 17, 2024 Filed May 22, 2024 01:20 UTC |
BOWMAN A BLAINEDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001415889-24-014043 · form4-05222024_010554.xml · derivative · entry 1 BOWMAN A BLAINE · CIK 0001008891 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-05-17 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such Change in Control. Read SEC document |
| May 17, 2024 Filed May 22, 2024 01:10 UTC |
WIDDER KENNETH JDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001415889-24-014038 · form4-05222024_010512.xml · derivative · entry 1 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-05-17 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such Change in Control. Read SEC document |
| May 17, 2024 Filed May 22, 2024 01:22 UTC |
Shoff LonnieDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001415889-24-014045 · form4-05222024_010537.xml · derivative · entry 1 Shoff Lonnie · CIK 0001471716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-05-17 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such Change in Control. Read SEC document |
| May 17, 2024 Filed May 22, 2024 01:13 UTC |
Tachibana AaronCFO AND COO
|
SaleCommon Stock | 1,333 | $1.38 | $1,839.54 |
DisclosureSEC source: 0001415889-24-014040 · form4-05222024_010559.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · CFO AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,188 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $1.34 to $1.47 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 17, 2024 Filed May 22, 2024 01:31 UTC |
MYERS WOODROW A JRDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001415889-24-014046 · form4-05222024_010511.xml · derivative · entry 1 MYERS WOODROW A JR · CIK 0001243399 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-05-17 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such Change in Control. Read SEC document |
| May 17, 2024 Filed May 22, 2024 01:21 UTC |
EASTHAM KARINDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001415889-24-014044 · form4-05222024_010557.xml · derivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-05-17 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such Change in Control. Read SEC document |
| May 17, 2024 Filed May 22, 2024 01:19 UTC |
Bloom Olivia KyusukDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001415889-24-014042 · form4-05222024_010500.xml · derivative · entry 1 Bloom Olivia Kyusuk · CIK 0001501545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-05-17 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such Change in Control. Read SEC document |
| May 17, 2024 Filed May 22, 2024 01:14 UTC |
Chen RichardCHIEF MEDICAL OFFICER AND EVP
|
SaleCommon Stock | 940 | $1.38 | $1,297.20 |
DisclosureSEC source: 0001415889-24-014041 · form4-05222024_010505.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,806 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $1.34 to $1.47 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · balance_after: Includes 4,876 shares acquired under the Issuer's Employee Stock Purchase Plan on April 30, 2024. Read SEC document |
| May 17, 2024 Filed May 22, 2024 01:11 UTC |
Moore Stephen MichaelSVP and Chief Legal Officer
|
SaleCommon Stock | 1,731 | $1.38 | $2,388.78 |
DisclosureSEC source: 0001415889-24-014039 · form4-05222024_010544.xml · nonDerivative · entry 1 Moore Stephen Michael · CIK 0001915342 · SVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,666 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $1.34 to $1.47 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 30, 2024 Filed May 2, 2024 21:52 UTC |
Moore Stephen MichaelSVP and Chief Legal Officer
|
SaleCommon Stock | 4,523 | $1.37 | $6,196.51 |
DisclosureSEC source: 0001415889-24-012065 · form4-05022024_090544.xml · nonDerivative · entry 1 Moore Stephen Michael · CIK 0001915342 · SVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,397 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:30 UTC |
Hall Christopher MDirector · PRESIDENT AND CEO
|
GrantStock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001415889-24-008533 · form4-03192024_040327.xml · derivative · entry 1 Hall Christopher M · CIK 0001449535 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2034-03-15 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2024. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:30 UTC |
Tachibana AaronCFO AND COO
|
GrantStock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001415889-24-008532 · form4-03192024_040321.xml · derivative · entry 1 Tachibana Aaron · CIK 0001401786 · CFO AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2034-03-15 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2024. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:30 UTC |
Chen RichardCHIEF MEDICAL OFFICER AND EVP
|
GrantStock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001415889-24-008530 · form4-03192024_040309.xml · derivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2034-03-15 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2024. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:30 UTC |
Moore Stephen MichaelGENERAL COUNSEL
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001415889-24-008531 · form4-03192024_040315.xml · derivative · entry 1 Moore Stephen Michael · CIK 0001915342 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2034-03-15 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2024. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:15 UTC |
MYERS WOODROW A JRDirector
|
PurchaseCommon Stock | 10,000 | $1.67 | $16,700.00 |
DisclosureSEC source: 0001415889-24-006773 · form4-03052024_100343.xml · nonDerivative · entry 1 MYERS WOODROW A JR · CIK 0001243399 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,116 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.65 to $1.67. The price reported above reflects the weighted average price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 21:27 UTC |
Tachibana AaronCFO AND COO
|
SaleCommon Stock | 716 | $1.37 | $980.92 |
DisclosureSEC source: 0001415889-24-002070 · form4-01312024_090149.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · CFO AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,521 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 21:30 UTC |
Chen RichardCHIEF MEDICAL OFFICER AND EVP
|
SaleCommon Stock | 526 | $1.37 | $720.62 |
DisclosureSEC source: 0001415889-24-002075 · form4-01312024_090126.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,870 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 23:07 UTC |
Tachibana AaronCFO and COO
|
SaleCommon Stock | 6,747 | $1.47 | $9,918.09 |
DisclosureSEC source: 0001209191-23-059242 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · CFO and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,237 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 23:09 UTC |
Chen RichardChief Medical Officer and EVP
|
SaleCommon Stock | 4,708 | $1.47 | $6,920.76 |
DisclosureSEC source: 0001209191-23-059243 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer and EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,396 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · balance_after: Includes 5,000 shares acquired under the Issuer's Employee Stock Purchase Plan ("ESPP") on April 28, 2023 and 5,000 shares acquired under the Issuer's ESPP on October 31, 2023. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 23:02 UTC |
Moore Stephen MichaelGeneral Counsel
|
SaleCommon Stock | 1,476 | $1.47 | $2,169.72 |
DisclosureSEC source: 0001209191-23-059241 · doc4.xml · nonDerivative · entry 1 Moore Stephen Michael · CIK 0001915342 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,920 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 21:30 UTC |
Tachibana AaronCFO and COO
|
SaleCommon Stock | 1,344 | $1.04 | $1,397.76 |
DisclosureSEC source: 0001209191-23-056066 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · CFO and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,984 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 21:30 UTC |
Moore Stephen MichaelGeneral Counsel
|
SaleCommon Stock | 1,722 | $1.04 | $1,790.88 |
DisclosureSEC source: 0001209191-23-056064 · doc4.xml · nonDerivative · entry 1 Moore Stephen Michael · CIK 0001915342 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,396 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 21:30 UTC |
Chen RichardChief Medical Officer and EVP
|
SaleCommon Stock | 940 | $1.04 | $977.60 |
DisclosureSEC source: 0001209191-23-056065 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer and EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,104 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| November 01, 2023 Filed Nov 4, 2023 01:00 UTC |
Hall Christopher MDirector · President and CEO
|
SaleCommon Stock | 20,459 | $0.93 | $19,026.87 |
DisclosureSEC source: 0001209191-23-054435 · doc4.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,541 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:21 UTC |
Tachibana AaronCFO and COO
|
SaleCommon Stock | 662 | $2.26 | $1,496.12 |
DisclosureSEC source: 0001209191-23-044217 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · CFO and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 193,328 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:20 UTC |
Chen RichardChief Medical Officer and EVP
|
SaleCommon Stock | 485 | $2.26 | $1,096.10 |
DisclosureSEC source: 0001209191-23-044216 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer and EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,044 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 20:49 UTC |
Tachibana AaronCFO and COO
|
SaleCommon Stock | 6,904 | $2.07 | $14,291.28 |
DisclosureSEC source: 0001209191-23-038810 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · CFO and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 193,990 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 20:52 UTC |
Moore Stephen MichaelGeneral Counsel
|
SaleCommon Stock | 1,509 | $2.07 | $3,123.63 |
DisclosureSEC source: 0001209191-23-038815 · doc4.xml · nonDerivative · entry 1 Moore Stephen Michael · CIK 0001915342 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,118 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 20:51 UTC |
Chen RichardChief Medical Officer and EVP
|
SaleCommon Stock | 4,817 | $2.07 | $9,971.19 |
DisclosureSEC source: 0001209191-23-038813 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer and EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,529 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| June 13, 2023 Filed Jun 14, 2023 22:20 UTC |
WIDDER KENNETH JDirector
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $2.31 | $0.00 |
DisclosureSEC source: 0001209191-23-037147 · doc4.xml · derivative · entry 1 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2033-06-12 F1 · derivative.exercise_date: The shares subject to the option vest in 3 annual installments with the first installment vesting on June 13, 2024. Read SEC document |
| May 17, 2023 Filed May 19, 2023 22:29 UTC |
BOWMAN A BLAINEDirector
|
GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001209191-23-031229 · doc4.xml · derivative · entry 1 BOWMAN A BLAINE · CIK 0001008891 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2033-05-17 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such Change in Control. Read SEC document |
| May 17, 2023 Filed May 19, 2023 22:33 UTC |
Shoff LonnieDirector
|
GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001209191-23-031233 · doc4.xml · derivative · entry 1 Shoff Lonnie · CIK 0001471716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2033-05-17 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such Change in Control. Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:42 UTC |
Tachibana AaronCFO and COO
|
SaleCommon Stock | 1,389 | $1.98 | $2,750.22 |
DisclosureSEC source: 0001209191-23-031182 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · CFO and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,894 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| May 17, 2023 Filed May 20, 2023 00:45 UTC |
MYERS WOODROW A JRDirector
|
GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001209191-23-031284 · doc4.xml · derivative · entry 1 MYERS WOODROW A JR · CIK 0001243399 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2033-05-17 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such Change in Control. Read SEC document |
| May 17, 2023 Filed May 19, 2023 22:37 UTC |
EASTHAM KARINDirector
|
GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001209191-23-031238 · doc4.xml · derivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2033-05-17 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such Change in Control. Read SEC document |
| May 17, 2023 Filed May 19, 2023 18:32 UTC |
Colowick AlanDirector
|
GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001209191-23-031231 · doc4.xml · derivative · entry 1 Colowick Alan · CIK 0001316163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2033-05-17 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such Change in Control. Read SEC document |
| May 17, 2023 Filed May 19, 2023 22:59 UTC |
Bloom Olivia KyusukDirector
|
GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001209191-23-031251 · doc4.xml · derivative · entry 1 Bloom Olivia Kyusuk · CIK 0001501545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2033-05-17 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such Change in Control. Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:39 UTC |
Moore Stephen MichaelGeneral Counsel
|
SaleCommon Stock | 1,781 | $1.98 | $3,526.38 |
DisclosureSEC source: 0001209191-23-031176 · doc4.xml · nonDerivative · entry 1 Moore Stephen Michael · CIK 0001915342 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,627 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.